Only 11% of pregnant women in the Centers for Disease Control and Prevention鈥檚 Vaccine Safety Datalink, which includes vaccine safety monitoring data from nine integrated health systems, were fully vaccinated against COVID-19 by May 8, compared with 25% of non-pregnant women, the CDC  today. Receipt of at least one dose of COVID-19 vaccine during pregnancy was highest among women aged 35-49 years (22.7%) and lowest among those aged 18-24 years (5.5%), and higher among Asian (24.7%) and white women (19.7%) than among Hispanic (11.9%) and Black women (6.0%).

鈥淭hese findings highlight racial and ethnic disparities in COVID-19 vaccination coverage to date among pregnant women, who are at increased risk for infection and severe COVID-19-associated illness, indicating a need to prioritize vaccine equity by addressing potential barriers and access issues,鈥 the authors said.
 

Related News Articles

Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium鈥
Headline
The AHA July 14 responded to a Department of Health and Human Services request for information regarding lawful regulation and innovation to promote better鈥
Headline
 The Food and Drug Administration July 10 approved Moderna鈥檚 Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that鈥
Headline
Duke University鈥檚 Anna Tharakan, lead project manager on Closing the Gap on Hypertension Disparities, and Bradi Granger, Ph.D., research professor at Duke鈥
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention鈥
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England鈥